Home / Sell by State / North Carolina
North Carolina · Sell-Side M&A
North Carolina enforces the corporate practice of medicine, so a non-physician buyer cannot take direct equity in your practice. The deal has to run through an MSO and friendly-PC structure instead. That structure is exactly where value is won or lost. We represent North Carolina owners only, and we build the deal around the rules instead of around the buyer.
A confidential ballpark in under two minutes, no email required.
North Carolina's Real Differentiator
North Carolina enforces the corporate practice of medicine. A non-physician, an ordinary corporation, or a private equity firm may not directly own or control a medical or medical-aesthetic practice here. The treating practice must be a professional corporation or PLLC owned by North Carolina-licensed physicians. That single rule is why a North Carolina sale is never an off-the-shelf company purchase, and why structure decides whether your deal closes and at what price.
The treating practice has to be a professional corporation or PLLC owned by North Carolina-licensed physicians. A PE firm or non-physician strategic cannot take direct equity in the treating PC, which is the starting point for every deal in the state.
The lawful path is an MSO and friendly-PC model: the buyer acquires or forms a management services organization that owns the non-clinical assets and provides administrative, marketing, real-estate, and back-office services under a long-term management services agreement, while the physician-owned PC keeps clinical control and licensure.
The MSO may not exert clinical control, and management fees must be fair market value. A straight percentage of medical revenue or profit is the structure to avoid. Getting the fee form right is a closeability and pricing issue, not a footnote.
North Carolina has seen proposed legislation to tighten common-ownership rules between MSOs and practices. Structures that look clean today can attract scrutiny, so physician-successor planning and a defensible MSO agreement matter before you go to market.
Statutory references come from North Carolina healthcare-M&A guidance, not a direct statutory quote: the Medical Practice Act at N.C. Gen. Stat. Sections 90-1 to 90-21, 21 NCAC 32B.0001, and the Professional Corporation Act in Chapter 55B. Enforcement is administrative and board-driven, supported by a 1955 N.C. Attorney General opinion that private corporations may not practice medicine for profit. Sources: Zivian Health and Permit Health North Carolina CPOM guides (linked in our sources).
| Metric | Figure | Note |
|---|---|---|
| North Carolina population | ~11.2M | Ninth-most populous US state |
| State-level med spa count | Not published | AmSpa reports national totals only |
AmSpa's State of the Medical Spa Industry report publishes a national med spa count only and includes no state-by-state breakdown or ranking. Population figure is a US Census Bureau estimate.
Market Reality
AmSpa's State of the Medical Spa Industry report publishes a national med spa count only, with no state-by-state breakdown or ranking, so we will not cite an uncitable North Carolina figure. What is verifiable is scale: North Carolina is the ninth-most populous state in the country at roughly 11.2 million residents, and the state pairs genuine depth with room to consolidate across the Research-Triangle and Charlotte corridor, which is exactly why national platforms keep buying here.
Run my numbers →See Your Number First
A confidential ballpark in under two minutes. No email required to see your range. The estimate is generated on your device. Nothing is stored or sent unless you choose to continue.
Step 1 · Instant ballpark
Estimated enterprise value
Practices like yours trade around 2.6x – 5.3x adjusted earnings.
What raises your number
What lowers your number
Step 2 · What you receive when you continue
Your custom valuation report. Comparable transactions, your likely buyer pool, and timing analysis.
Your buyer-readiness scorecard. The specific moves that raise your multiple before you go to market.
A confidential 30-minute strategy call with Bill Walker. No obligation, no pressure.
Your information is never shared, and we have never broken a client's confidentiality.
Estimate only. A ballpark from limited inputs plus published industry M&A benchmarks.
What Moves Value Here
No North Carolina-specific sale multiple is published, and we will not invent one. The honest anchor is the national vertical range already on our med spa, cosmetic dermatology, and plastic surgery hubs. What changes a North Carolina seller's realized value is how the deal has to be built and how cleanly it clears the state's corporate-practice rules.
Because the deal runs through an MSO and friendly-PC wrap rather than a clean direct equity sale, value shifts toward the MSO management contract and the durability of the PC relationship. How earnouts and rollover equity are papered, and where value sits, all follow from the structure.
Map my structure →North Carolina enforcement raises buyer diligence on fair-market-value management fees, the absence of MSO clinical control, and supervision compliance. A clean, pre-structured compliant entity reduces buyer risk discounts and re-trading.
See the structure rules →Because the PC must stay physician-owned, a credible physician-successor plan is a value lever, not a formality. National platforms are actively buying in North Carolina, and a well-prepared seller is the one who holds the national range.
Who is buying →We reference the national vertical multiple range published on our practice-type hubs. We do not publish a North Carolina-specific multiple, because none exists in a citable, defensible form. Your real range comes from a confidential, practice-specific analysis of your earnings, your structure, and your comps.
Who Is Actually Buying in North Carolina
A North Carolina seller does not depend on one local acquirer. Two private-equity-backed platforms have documented, in-state North Carolina footprints, and both are owned or recapitalized by named PE firms. We will never name a "local buyer" that does not exist.
Detail bars are redacted by design. Every name and activity claim on this board is published from verifiable records; anything beyond the public record stays confidential.
Anne Arundel (Ridgemont Equity Partners, Oct 2020; 74 clinics across five states including North Carolina at exit; 16 NC locations today) and Forefront Dermatology (Partners Group, ~$1.5B Feb 2022; eighth NC location, Charlotte, Oct 2025) are the in-state proof points, documented in NMS Capital, Partners Group, Axios, Forefront, and Anne Arundel sources. The 35-plus platform count and 73% add-on share are national consolidation context per Practical Dermatology. No local-only buyer is asserted.
North Carolina Sale FAQ
Not the way they would buy a normal business. North Carolina enforces the corporate practice of medicine, so a non-physician, an ordinary corporation, or a private equity firm cannot directly own a medical or medical-aesthetic practice or control clinical decisions. The treating practice must be a professional corporation or PLLC owned by North Carolina-licensed physicians. The lawful path for a buyer is the MSO and friendly-PC model: a physician-owned PC keeps the clinical practice and licensure, and a separate management services organization, the part the investor owns and funds, contracts to provide non-clinical business services for a fee. That is why a North Carolina sale is a structured transaction, not a simple stock or asset sale.
Per North Carolina healthcare-M&A guidance, enforcement is administrative and board-driven rather than built on controlling appellate case law. The North Carolina Medical Board oversees the doctrine, supported by a 1955 North Carolina Attorney General opinion that private corporations may not practice medicine for profit. The guidance points to the Medical Practice Act at North Carolina General Statutes Sections 90-1 to 90-21 and to 21 NCAC 32B.0001, which bar unlicensed persons and entities from diagnosing or treating, while the Professional Corporation Act in Chapter 55B governs the professional-entity form. These citations come from healthcare-M&A explainers rather than a direct statutory quote.
The management services organization may not exert clinical control, and the management fee must be set at fair market value. A straight percentage of medical revenue or profit is the structure to avoid. North Carolina has also seen proposed legislation to tighten common-ownership rules between MSOs and practices. This is the central reason a seller should pre-structure a compliant PC and MSO before going to market: fee-structure compliance, the absence of clinical control by the MSO, and a credible physician-successor plan are deal-defining, and getting them right protects both the ability to close and the price.
No. There is no published North Carolina-specific multiple, and we will not quote one. What we use is the national vertical range for your practice type, then we explain how North Carolina law and market move structure and value. Because the state strictly enforces the corporate practice of medicine, the achievable form is an MSO and friendly-PC arrangement rather than a clean direct equity sale, which shifts where value sits and raises diligence weight on fair-market-value management fees and physician-successor continuity. A cleanly pre-structured entity and a credible successor plan are the levers that protect value. Your real number comes from a confidential, practice-specific analysis.
Demand is national, and two private-equity-backed platforms have verifiable North Carolina footprints. Forefront Dermatology, owned by Partners Group following a roughly 1.5 billion dollar transaction announced in February 2022, operates more than 200 clinics across 22 or more states and opened its eighth North Carolina location in Charlotte on October 1, 2025. Anne Arundel Dermatology, recapitalized by Ridgemont Equity Partners in October 2020, operated 74 clinics across five states including North Carolina at that exit and today lists 16 North Carolina locations across 11 cities. The accurate picture is well-capitalized national platforms and PE-backed MSOs buying in North Carolina, not a single local acquirer.
North Carolina is a substantial medical spa market. AmSpa’s State of the Medical Spa Industry report publishes a national med spa count only, with no state-by-state breakdown or ranking, so we will not cite an uncitable North Carolina figure. What is verifiable is scale: North Carolina is the ninth-most populous state in the country, with roughly 11.2 million residents per US Census Bureau estimates, and the opportunity is the depth of the market across the Research-Triangle and Charlotte corridor rather than a single hotspot.
Yes, unless and until you choose to tell people. We run every process under strict confidentiality, with confidentiality agreements, secure data rooms, staged disclosure, and a vetted buyer process. Premature disclosure can unsettle staff, shake patient confidence, and weaken your negotiating position, so you decide what is shared, with whom, and when. Confidentiality also protects the compliance work, because the friendly-PC and MSO structure and physician-successor plan are mapped privately with you before any buyer sees them.
Match Your Practice Type
How recurring and membership revenue, provider capacity, and key-person risk set a med spa's value, paired with the North Carolina structure work above.
Med spa sell-side →Where North Carolina's in-state derm activity is happening, and how a cosmetic derm practice is valued for sale.
Cosmetic derm sell-side →The valuation and deal-structure work for a surgical aesthetic practice, mapped to North Carolina's corporate-practice rules.
Plastic surgery sell-side →By Metro
Compare every market on the Sell by State directory.
Charlotte deal activity and how a North Carolina sale is built.
Selling in Charlotte →
Who you work with
Bill Walker founded Aesthetic Brokers after leading mergers and acquisitions for a large private-equity-backed healthcare services organization. Before that he flew for the Marine Corps at the Presidential Helicopter Squadron and commanded a squadron in combat. He knows how an investor values a practice, and how to make sure that value lands with you, not the buyer.
Talk with Bill about your practiceStart with a confidential, two-minute read on where you stand.
